Search

Displaying results 4511 - 4520 of 10000 in total
  1. Drug

    Poziotinib

    go.drugbank.com/drugs/DB12114
    Investigational

    Poziotinib has been used in trials studying the treatment of Breast Cancer, Metastatic Breast Cancer, Increased Drug Resistance, Adenocarcinoma of Lung Stage IV, and Adenocarcinoma of Lung Stage IIIB, among others.

    Categories: Heterocyclic Compounds, 2-Ring
  2. Drug

    Gevokizumab

    go.drugbank.com/drugs/DB12119
    Investigational

    Gevokizumab acts as a modulator of cytokine imbalance in IL-1 mediated disease states. It has a very high binding affinity of 300fM and blocks the activation of IL-1 receptors.

  3. Drug

    Cinepazide

    go.drugbank.com/drugs/DB12123
    Investigational

    Cinepazide has been used in trials studying the treatment of Ischemic Stroke.

    Categories: Heterocyclic Compounds, 1-Ring
  4. Drug

    Bradykinin

    go.drugbank.com/drugs/DB12126
    Investigational

    Bradykinin has been investigated for the basic science and treatment of Hypertension and Diabetes Type 2.

    Synonyms: L-bradykinin
  5. Drug

    GSK-256066

    go.drugbank.com/drugs/DB12137
    Investigational

    Gsk256066 has been used in trials studying the treatment and diagnostic of SAR, Asthma, Mild Asthma, Allergic Rhinitis, and Seasonal Allergic Rhinitis, among others.

    Categories: Heterocyclic Compounds, 2-Ring, Phosphodiesterase 4 Inhibitors
  6. Drug

    AZD-0328

    go.drugbank.com/drugs/DB12145
    Investigational

    AZD0328 has been used in trials studying the treatment and basic science of Schizophrenia and Alzheimer's Disease.

    Categories: Heterocyclic Compounds, 1-Ring
  7. Drug

    Erdafitinib

    go.drugbank.com/drugs/DB12147
    ApprovedInvestigational

    tool kit to treat such a prevalent medical condition. … [L5956, L5959] At the same time, the FDA also approved the therascreen FGFR RGQ RT-PCR Kit (Qiagen) for utilization as a companion diagnostic with erdafitinib for selecting patients for the indicated therapy

    Categories: Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates with a Narrow Therapeutic IndexProducts: BALVERSA 3 MG FİLM KAPLI TABLET, 56 ADET, BALVERSA 3 MG FİLM KAPLI TABLET, 84 ADET
  8. Drug

    Menatetrenone

    go.drugbank.com/drugs/DB12148
    Investigational

    Menatetrenone has been used in trials studying the treatment of Diabetes, Osteoporosis, Prediabetic State, and Hepatocellular Carcinoma.

    Categories: Vitamin K
  9. Drug

    Brincidofovir

    go.drugbank.com/drugs/DB12151
    ApprovedInvestigational

    [A235725,A235735] Due to its formulation as a pro-drug brincidofovir also carries a greater bioavailability than cidofovir,[A235740,A235725] allowing for oral administration rather than intravenous. … It is a lipid conjugate pro-drug of the acyclic nucleotide analogue [cidofovir][L34404,A235725] - this lipid conjugate improves drug delivery to the target cells and significantly reduces the nephrotoxicity

    Categories: Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, 1-Ring
  10. Drug

    Citicoline

    go.drugbank.com/drugs/DB12153
    ApprovedInvestigationalWithdrawn

    Citicoline is a donor of choline in biosynthesis of choline-containing phosphoglycerides.

    Categories: Heterocyclic Compounds, 1-RingSynonyms: Cytidine 5'-diphosphocholine, Cytidine-5'-diphosphocholine